B cells of CLL patients are known to express varying levels of CR3 and CR4 [4, 13–19], however, the function of these receptors on CLL cells and their contribution to the pathogenesis of the disease is unexplained. This evidence concerns the gene CRIPTO3 and B-cell chronic lymphocytic leukemia.